Chaitra Ujjani, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Atara
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    AstraZeneca
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pharmacyclics
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Janssen
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Abbvie
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Genentech
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Epizyme
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Incyte
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Beigene
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Eli Lilly
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
Return to Seattle Cellular Therapy Summit: Patient-Centered Approach to Improve Outcomes